Farydak
Drug
Secura Bio, Inc.
Total Payments
$69,127
Transactions
1,060
Doctors
579
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $69,127 | 1,060 | 579 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,450 | 9 | 39.7% |
| Honoraria | $24,350 | 14 | 35.2% |
| Food and Beverage | $14,000 | 1,010 | 20.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,326 | 23 | 3.4% |
| Travel and Lodging | $1,000 | 4 | 1.4% |
Top Doctors Receiving Payments for Farydak — Page 24
Ad
Manufacturing Companies
- Secura Bio, Inc. $69,127
Product Information
- Type Drug
- Total Payments $69,127
- Total Doctors 579
- Transactions 1,060
About Farydak
Farydak is a drug associated with $69,127 in payments to 579 healthcare providers, recorded across 1,060 transactions in the CMS Open Payments database. The primary manufacturer is Secura Bio, Inc..
Payment data is available from 2020 to 2020. In 2020, $69,127 was paid across 1,060 transactions to 579 doctors.
The most common payment nature for Farydak is "Consulting Fee" ($27,450, 39.7% of total).